Harold Woods is currently the Senior Director of Facilities, Engineering & Technical Operations at Immatics, where he leads engineering, facilities management, construction, asset lifecycle, supply chain and technical operations across U.S. sites. Holding a B.S. in Mechanical Engineering and an M.Eng. in Engineering Management; he is accountable for maintaining controlled GMP environments and sustaining compliance with FDA and global GMP expectations through disciplined maintenance programs, validated utilities, and rigorous EHS oversight. Harold partners with Quality, Manufacturing, and R&D to align change control, calibration, and preventive maintenance with production needs, while ensuring cleanroom performance, HVAC/BMS operations, and critical utilities remain in state of control. Over a 25-year career in biopharma and advanced manufacturing, he has built high-performing teams and held leadership roles at Kiromic BioPharma, Catalent, Lonza, Cosentino, and Katoen Natie, following earlier engineering leadership at Alcon Laboratories and 13 years in the U.S. Navy. His expertise spans reliability engineering, CMMS-driven maintenance excellence, environmental monitoring support, automation, SCADA/BMS integration, and total cost of ownership optimization. Known for audit-ready operations, uptime, and safety, he delivers capital projects and turnarounds on time and within budget.

The Pop in Your Job: I take pride in building environments where life-changing therapies can be made safely, repeatably, and at scale. The work blends mission and mechanics: translating clinical intent into robust facilities, resilient utilities, and right-sized operations that run smoothly every day. Just as important, I love building teams. I look for strengths, pair them thoughtfully, and use them to offset gaps so the group can tackle whatever comes down the pipeline. I get more satisfaction from a crew win than any title, especially when a tech’s idea makes the line run better than the original plan (which happens more than you think). My style is disciplined execution, low drama, and lots of data, plus enough humor to keep stand-ups human. The best moments are inspection-ready days when the lines hum, the team feels supported, safe, and we know patients will benefit from the work behind the walls.

Immatics is a clinical-stage biopharmaceutical company focused on T-cell–redirecting immunotherapies for cancer. We pair precise target discovery with T-cell receptor engineering to create two complementary approaches: personalized TCR-T cell therapies and TCR bispecifics called TCER. We are the world leader in precision targeting of PRAME, a cancer target found in more than 50 tumor types, and we are advancing the broadest PRAME franchise across multiple indications and modalities. Our teams in Tübingen, Munich, and the Houston area share a simple purpose: deliver the power of T cells to patients and make their lives better. We believe great science should also be practical, which is why we focus on reliable manufacturing, thoughtful study design, and clear data that can move treatments to patients sooner. Day to day, that looks like careful lab work, steady progress, and a lot of collaboration. The impact we aim for is straightforward: safer, more effective options to give better times for people living with cancer.